Sessioni Comunicazioni Orali


Miscellaneous Pharmacology

Wednesday, October 25th / 14.30-16.30
69BUTYRATE REDUCES VALPROATE-INDUCED HEPATOTOXICITY, OXIDATIVE STRESS AND MITOCHONDRIAL DYSFUNCTION IN HEPG2 CELL LINE
Pirozzi C., Lama A., Di guida F., Annunziata C., Nitrato izzo A., Cavaliere G., Trinchese G., Russo R., Mollica MP., Mattace raso G., De sarro G., Calignano A., Meli R.
70SEX-DEPENDENT ROLE OF LEUKOTRIENES IN AIRWAY HYPERREACTIVITY AND PULMONARY INFLAMMATION IN AN EXPERIMENTAL MODEL OF ALLERGEN SENSITIZATION
Rossi A., Roviezzo F., Sorrentino R., Pinto A., Werz O., D'agostino B., Cirino G., Sautebin L.
71COMPARATIVE PRE-CLINICAL STUDY ON THE EFFECTS OF APIXABAN AND DABIGATRAN ON INTESTINAL MUCOSA
Benvenuti L., Fornai M., Antonioli L., Pellegrini C., Natale G., Fulceri F., Limanaqi F., Tirotta E., Gentile D., Colucci R., Blandizzi C.
72REMODELING OF ATRIAL REPOLARIZATION AND ATRIAL CHAMBER DEFORMATION: A POTENTIAL LINK IN THE DEVELOPMENT OF ATRIAL FIBRILLATION?
Sartiani L., Cameli M., Dini L., Mondillo S., Maccherini M., Le grand B., Mugelli A., Cerbai E.
73In vitro effects of mediators derived from porcine vascular stem cells on intestinal expression of cannabinoid and opioid receptors under inflammatory conditions.
Dothel G., Asteriti E., Mazzarella A., Bernardini C., Zannoni A., Forni M., De ponti F.
74PALMITOYLETHANOLAMIDE IMPROVES HIV-1 TAT-INDUCED DIARRHEA ACTING THROUGH SELECTIVE PPARalpha-DEPENDENT INHIBITION OF ENTERIC GLIAL CELLS ACTIVATION
Sarnelli G., Gigli S., Seguella L., Steardo L., Esposito G.
75Insulin analogue glargine 300 U/mL and 100 U/mL: the same active principle with a higher concentration involves a reduced subcutaneous depot and a different insulin dissolution rate, determining an improved clinical-pharmacological drug profile.
Angelini J., Pani A., Nunnari P., Rucci F., Marino R., Scaglione F.
76THE ANTI-INFLAMMATORY PROTEIN ANNEXIN A1 AS NEW PHARMACOLOGICAL APPROACH TO COUNTERACT THE DELETERIOUS EFFECTS OF DIET-INDUCED METABOLIC DERANGEMENTS.
Chiazza F., Purvis GS., Chen J., Martin L., Collotta D., Mastrocola R., Nigro D., Aragno M., Cutrin JC., Yaqoob MM., Fantozzi R., Solito E., Thiemermann C., Collino M.
77PCSK9 (PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9) DEFICIENCY REDUCES INSULIN SECRETION AND PROMOTES GLUCOSE INTOLERANCE: THE ROLE OF THE LDL RECEPTOR
Balzarotti G., Ruscica M., Di cairano E., Perego C., Catapano AL., Norata GD.